January 21, 2026
EmbryoScope® Technology Boosts IVF Success Rates
Fertility Centers of New England pioneered the EmbryoScope®, a time-lapse imaging system that improves IVF outcomes by minimizing embryo handling and enabling precise selection of blastocysts. The clinic reports pregnancy rates validated by a 2014 Fertil Steril study, with single embryo transfers recommended for patients under 38 to reduce twin pregnancy risks. Patients seeking advanced fertility solutions are encouraged to contact their locations in Massachusetts, New Hampshire, Maine, and Rhode Island.
Key Takeaways
How EmbryoScope® Time-Lapse Imaging Enhances IVF Outcomes
The EmbryoScope® uses automated time-lapse photography to monitor embryos continuously in an undisturbed incubator environment, reducing handling and improving embryo survival rates compared to traditional methods.
Single Embryo Transfer for Patients Under 38: Reducing Risks
Elective single embryo transfers (SET) are recommended for patients under 38 to prioritize singleton pregnancies, lowering pregnancy complications while leveraging EmbryoScope®-gained insights to select the strongest blastocyst.
Who Benefits Most from EmbryoScope® Technology?
Patients with prior IVF failures or those undergoing blastocyst transfers (day 5) benefit most from EmbryoScope® technology, which provides detailed morphokinetic data to optimize embryo selection.
EmbryoScope® Validation by 2014 Fertil Steril Study
A 2014 randomized controlled trial published in Fertil Steril confirmed the EmbryoScope®’s clinical effectiveness in improving pregnancy rates through precise morphokinetic analysis of embryo development.
Fertility Centers of New England’s Leadership in IVF Innovation
As the first U.S. clinic to report a pregnancy with EmbryoScope®, FCNE emphasizes its role in setting industry standards for advanced infertility treatment, with locations across New England offering this cutting-edge technology.
Source: Read full article